Curative Biotechnology, Inc.
CUBT
$0.0115
-$0.0003-2.54%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.15M | 2.27M | 4.35M | 4.21M | 8.37M |
| Depreciation & Amortization | 8.00K | 8.00K | 8.00K | 6.80K | 6.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.27M | 4.05M | 5.68M | 5.00M | 8.60M |
| Operating Income | -4.27M | -4.05M | -5.68M | -5.00M | -8.60M |
| Income Before Tax | -5.04M | -4.64M | -5.94M | -5.34M | -9.00M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.04 | -4.64 | -5.94 | -5.34 | -9.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.04M | -4.64M | -5.94M | -5.34M | -9.00M |
| EBIT | -4.27M | -4.05M | -5.68M | -5.00M | -8.60M |
| EBITDA | -4.26M | -4.05M | -5.67M | -4.99M | -8.59M |
| EPS Basic | -0.03 | -0.03 | -0.04 | -0.07 | -0.06 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.04 | -0.07 | -0.06 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.71B | 2.25B | 2.21B | 2.01B | 1.78B |
| Average Diluted Shares Outstanding | 2.28B | 2.25B | 2.21B | 2.01B | 1.78B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
